Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8714535 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 13 Pages |
Abstract
Patients with CVID delay and avoid treatment of symptomatic respiratory exacerbations, which could result in structural lung damage. However, viruses are commonly represented and illnesses dominated by upper respiratory tract symptoms respond poorly to antibiotics, suggesting that antibiotic usage could be better targeted.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Johannes M. MD, Bodo MD, Sarita MSc, Tanzina MD, PhD, Suranjith L. MD, DPhil, Siobhan O. MD, PhD, Veronika MSc, Werner PhD, John R. MD, PhD, David M. MD, PhD,